The modestly higher exposure in Japanese participants is not considered to be a clinically meaningful difference because of the mainly uneventful safety profile of BIIB092 and the lack of any exposure-related AEs observed in this study
The modestly higher exposure in Japanese participants is not considered to be a clinically meaningful difference because of the mainly uneventful safety profile of BIIB092 and the lack of any exposure-related AEs observed in this study. solitary intravenous infusion of placebo or BIIB092 at doses of 21, 70, 210, 700, 2100, or 4200?mg (or 700…